Rapid Antigen tests aim to confirm positive test results of covid-19 infection in people possessing potential symptoms related to the disease. The rapid antigen home tests are accessible as they can be used wherever the patient is and can provide the test results quickly.Read More
The Ministry of Health and Family Welfare (MoHFW) has notified the Cosmetics Rules, 2020 under the Drugs and Cosmetics Act, 1940. This move is to streamline all functions and bring effective compliance in the cosmetic sector of India. The notification came to separately codify and update the rules relating to import, manufacture, labeling, sale, and distribution of cosmetics in India, which were earlier set out under the Drugs and Cosmetics Rules, 1945.Read More
CDSCO has notified four medical devices, i.e., nebulizer, blood pressure monitoring devices, digital thermometer, and glucometer as drugs. The importers and manufacturers of these 4 medical devices need to take import and manufacturing licenses from the Central Licensing Authority or State Licensing Authority effectively from 1st January 2021.Read More
The Government of India has laid out guidelines for the Restricted use of vaccines in Emergency situations. The guidelines also allow the ready-to-use vaccine to be fully utilized from 1st May.Read More
The Ministry of Health and Family Welfare has recently come up with a release of notification dated 21st October 2020 to extend the timeline from 1st day of November, 2020” to the 1st day of November, 2021 for Ultrasound EquipmentRead More
To put regulations on this matter, Central Drugs Standard Control Organisation (CDSCO) made a list of 294 FDCs, and directions are given to all State/UT Drug Controllers of India to withdraw 294 FDCs from the licensed market the consent of DCGI. Court then got it to stay order in favour of the Manufacturers AssociationRead More
Drugs Controller General of India (DCGI) has further extended the deadline by four months to submit notarized or apostilled regulatory documents for import and registration of cosmetics such as Authorisation from Manufacturer, free sale certificate (FSC) with legal signatures. This is in continuation to the notices given on April 20, 2020, August 19, 2020, and December 18, 2020.
The Government of India has ordered to regulate the equipment for CT scan, MRI, defibrillators, PET, dialysis, X-ray, etc. as drugs from April 01, 2021.
NIB Noida is evaluating samples of in-vitro Diagnostics of 4th generation HIV kits for QC evaluation. While evaluating NIB, Noida noticed that many manufacturers of such Kits are not mentioning sensitivity for HIV P-24 antigen in the product insert. All the manufacturers or licensees are requested to update the product insert of these 4th generations HIV In-vitro diagnostic kits for inclusion of analytical sensitivity for HIV P-24 antigen so that there is no unnecessary delay in evaluation